kalarx-com / rounds / 2021-11-15
status=sourced json
| announced | 2021-11-15 | D |
|---|---|---|
| amount | 16,122,54116.1M USD | D |
| lead | null | D |
| participants | null | D |
| previous | 2016-04-06 Funding round 67,921,79667.9M |
| person | role | side | src |
|---|---|---|---|
| Andrew L. Koven | Director | company | D |
| C. Daniel Myers | Director | company | D |
| Darius Kharabi | Executive Officer | company | D |
| Eric L. Trachtenberg | Executive Officer | company | D |
| Gregory D. Perry | Director | company | D |
| Gregory Grunberg | Director | company | D |
| Hongming Chen | Executive Officer | company | D |
| Howard B. Rosen | Director | company | D |
| Kim Brazzell | Executive Officer | company | D |
| Mark Iwicki | Director, Executive Officer | company | D |
| Mark S. Blumenkranz | Director | company | D |
| Mary Reumuth | Executive Officer | company | D |
| Robert Paull | Director | company | D |
| Todd Bazemore | Executive Officer | company | D |